Form 4: Ani Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
Stephen P. Carey, SVP & CFO of Ani Pharmaceuticals Inc, sold 2,850 shares of common stock on July 29, 2026 for $81.36 per share.
Summary
- Open-market sale: disposed of 2,850 Common Stock at $81.36 ($231,876) on July 29, 2026; holds 174,693 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $231,876 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Stephen P. Carey — Officer (SVP & CFO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-29 | Open-market sale | Common Stock | 2,850 | $81 | $231.9K | 174,693 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-29 | Open-market sale (2,850 shares) |
Keywords
insider transaction, Form 4, ANIP, ANI PHARMACEUTICALS INC, bearish, Stephen P. Carey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.